Presentation EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial Presenter: Deepak L. Bhatt March 30, 2020 REGISTER for free or LOG IN to view this content Clinical Cardiology Prevention Clinical Pharma Lipids Coronary CAD Pharma Presentation ACC 2020 Icosapent ethyl EPA Vascepa Amarin Up Next Presentation Alirocumab Efficacy And Safety In Adults With Homozygous Familial Hypercholesterolemia (ODYSSEY HoFH) Presenter: Dirk J. Blom March 30, 2020 More slides + Presentation Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI April 15, 2020 Presentation Incidence, Presentation, and Causes of 30-Day Readmission After Hospitalization With SCAD April 20, 2020 We Recommend
Presentation Alirocumab Efficacy And Safety In Adults With Homozygous Familial Hypercholesterolemia (ODYSSEY HoFH) Presenter: Dirk J. Blom March 30, 2020
Presentation Incidence, Presentation, and Causes of 30-Day Readmission After Hospitalization With SCAD April 20, 2020